| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 970 | 1,236 | 1,540 | 1,196 | | Cost of Revenue | 534 | 763 | 1,152 | 705 | | | Gross Profit | 436 | 473 | 388 | 491 | | | Operating Expenses | | Research Development | 1,401 | 1,282 | 1,131 | 1,410 | | Selling General and Administrative | 2,340 | 2,861 | 2,769 | 2,439 | | Non Recurring |
-
| (250) | 250 |
-
| | Others | 337 | 333 | 346 | 347 | | | | Total Operating Expenses |
-
| 4,226 | 4,496 |
-
| | | | Operating Income or Loss | (4,260) | (3,753) | (4,108) | (3,705) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 979 | 142 | (1,511) | (702) | | Earnings Before Interest And Taxes | (2,770) | (4,122) | (5,619) | (3,670) | | Interest Expense | 531 | 509 | 513 | 454 | | Income Before Tax | (3,301) | (4,631) | (6,132) | (4,124) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,919) | (4,631) | (6,132) | (4,124) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,301) | (4,631) | (6,132) | (4,124) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,301) | ($4,631) | ($6,132) | ($4,124) |
|
0.51% Nasdaq 
0.05 (0.82%) 
Income Statement
